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associated with E. faecium swine
strains, might mirror wide dissemina-
tion of a host-specific clone more
prone than others to acquire and
spread different antimicrobial resist-
ance, as reported for human clinical E.
faecium isolates (9). Since enterococ-
ci from swine are able to colonize in
the human gut (5,7) and isolates har-
boring purK-9 can be recovered from
hospitalized patients with severe
infections (10), specific swine entero-
coccal strains might represent a risk
for antimicrobial resistance spread in
the clinical setting. Further analyses
need to be performed to understand
the role of international animal move-
ments, animal feed, and colonized
farmers in the spread of this particular
strain and to assess whether this clone
shows an increased fitness in the
porcine intestine when compared to
other E. faecium strains.
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Rabies Vaccine
Baits, Pennsylvania
To the Editor: Oral rabies vaccine
(ORV) programs control rabies in ter-
restrial reservoir species by distribut-
ing vaccine in baits (1). The current
US-licensed ORV consists of a rabies
virus glycoprotein gene inserted into
the thymidine kinase gene of an atten-
uated strain of the Copenhagen vac-
cinia virus (V-RG) (2). Safety experi-
ence includes extensive animal stud-
ies (2,3) in which significant adverse
effects were seen only with parenteral
(but not mucosal) exposure of nude
mice to V-RG (4). Usage monitoring
(4,5) found only 1 human adverse
complication to date (6). 
We report our experience monitor-
ing pet and human exposure to V-RG
as part of a multiagency federal-state
cooperative program that distributed
1,710,399 V-RG-laden baits from
August 11, 2003, to September 17,
2003, over 25,189 km2 of western
Pennsylvania (human population ≈3
million). The baits consisted of a vac-
cine-filled plastic sachet surrounded
by a fishmeal polymer. Workers dis-
tributed these baits on the ground from
vehicles or by air from fixed-wing air-
craft using conveyor belts. Aircraft did
not release baits when over homes or
other areas where humans or pets were
likely to be present. Given the limita-
tions of dispersing 1,421,517 baits at a
frequency of 75 to 150 baits/km2 from
200 m in the air, human habitat could
not be totally avoided.
Each bait was printed with a toll-
free phone number. Phone calls were
routed to a local or district health
department where an ORV-specific
form adapted from the Ohio State
Health Department was used to col-
lect uniform information about bait
contact.
During the 2003 campaign,
Pennsylvania health departments and
districts received 105 reports from
persons who found 190 baits. This
rate of reporting, 6.1 per 100,000
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baits, is in the midrange of other pub-
lished reports (0.12–50 per 100,000
baits) (5,6).
Of the 105 reports, 69 involved
persons who picked up or had other
skin contact with baits, and 8 reported
likely contact with vaccine. Four
involved persons who were hit by
baits from the air. Seventy reports
involved a pet or pets. In 66 reports,
the pet was a dog. In 56 reports, a dog
picked up the bait in its mouth. Eight
of these dogs ate the bait, and another
6 ruptured the plastic sachet.
The only definite human exposure
to vaccine occurred when a dog rup-
tured a bait and contaminated its
owner’s hands. Seven reports of pos-
sible human contact with vaccine
involved 10 persons. No documented
adverse reactions were associated
with any definite or potential human
exposures. 
Of the 7 reports of possible human
vaccine exposures, 3 incidents (4 per-
sons) involved owners who put hands
or fingers in a dog’s mouth to retrieve
a bait, 1 incident involved a dog that
licked 2 children right after rupturing
the bait, and 2 incidents (3 persons of
whom 2 were children) involved pick-
ing up a potentially ruptured bait. 
The final possible exposure to vac-
cine involved 1 of 4 persons hit by a
bait. This person reported that after
being struck, pink liquid spilled out of
the bait. The bait was examined by
program personnel and appeared to be
intact. The other 3 persons (including
1 child) hit by baits did not report vac-
cine contact or injury.
One uninsured person, who was
sent to a hospital emergency room
because of potential vaccine exposure
to the eye, signed out against medical
advice to avoid receiving a bill. This
person was seen by a family nurse
practitioner 2 weeks later. Results of
an examination were normal, and the
person refused to have blood drawn
for rabies or vaccinia titers.
Eleven children were involved in 9
credible incidents. In addition to the
previously described children, 6 chil-
dren picked up intact baits. We
received 2 noncredible reports: a child
with a dog ate a bait and a child licked
a bait. In the first case, the child was
in a different city at the time the
alleged incident occurred, and in the
second case, the caller refused to sup-
ply any information that could be used
to validate the episode. 
Posters, brochures, a press confer-
ence, and press releases have been
used to educate the public to take pre-
cautions (for example, wash exposed
skin and never remove bait from an
animal’s mouth) necessary to protect
the most vulnerable. Callers were
asked questions to determine their
ORV awareness. Seventy-nine callers
(75%) did not know about ORV activ-
ities, and 75 (71%) did not know what
the bait was before speaking with us.
Those who did know about the pro-
gram had most often learned about
ORV programs through paid radio
announcements in neighboring Ohio.
Modifications for 2004 included
an increase in media outreach in
smaller markets and increased hand
baiting. We received fewer reports
(51, or 2.9 per 100,000 baits) of per-
sons finding baits in 2004.
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